Waterloo Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Sell
752
-2,437
-76% -$1.03M 0.02% 451
2026
Q1
$1.51M Buy
3,189
+204
+7% +$103K 0.11% 171
2025
Q4
$1.39M Buy
2,985
+2,014
+207% +$935K 0.1% 174
2025
Q3
$414K Buy
971
+189
+24% +$73.3K 0.03% 315
2025
Q2
$300K Buy
782
+131
+20% +$47.2K 0.02% 351
2025
Q1
$225K Buy
+651
New +$209K 0.02% 363
2024
Q4
– Sell
-970
Closed -$394K – 372
2024
Q3
$394K Buy
+970
New +$355K 0.04% 276
2024
Q2
– Sell
-816
Closed -$272K – 363
2024
Q1
$272K Buy
+816
New +$249K 0.03% 300
2023
Q2
– Sell
-968
Closed -$255K – 229
2023
Q1
$255K Buy
+968
New +$246K 0.08% 153

Other funds holding HCA

Waterloo Capital's HCA Position: Q2 2026 in Review

Waterloo Capital reduced its HCA Healthcare (HCA) stake by 76% in Q2 2026, selling an estimated $1.03M and leaving 752 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #451.

Waterloo Capital first reported a position in HCA in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.51M in Q1 2026. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Waterloo Capital held 752 shares of HCA Healthcare worth $293K as of Q2 2026.
  • Waterloo Capital sold 2,437 HCA Healthcare shares in Q2 2026, an estimated $1.03M.
  • HCA Healthcare made up 0.02% of Waterloo Capital's portfolio in Q2 2026, its #451 holding.
  • Waterloo Capital first reported a position in HCA Healthcare in Q1 2023 and has held it in 9 quarters since.
  • Waterloo Capital's HCA Healthcare position peaked at $1.51M in Q1 2026.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.